ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryMeyrinOM Pharma SA
OM Pharma SA Logo
Verified· 4 sourcesTrust Score
Summary

About the company

OM Pharma SA is a biopharmaceutical company that develops and manufactures medicines based on bacterial lysates. The company conducts research and clinical trials, operates manufacturing facilities and distributes its product portfolio through international partnerships.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.2/5

OM Pharma SA

✓ Offered4
Bacterial lysates
Bacterial lysates for the prevention of recurrent respiratory and urinary tract infections; therapies derived from selected bacterial strains to train and strengthen the immune system.
Pharmaceutical products
Products for respiratory and urinary tract infections, chronic venous insufficiency, microangiopathy, haemorrhoids and menometrorrhagia; broad portfolio with BRONCHO-VAXOM®, URO-VAXOM®, DOXIUM®, DOXIPROCT®/DOXIPROCT PLUS® and DICYNONE®.
Biotechnological manufacturing
Manufacturing of bacterial lysates on the biotech campus in Geneva, from bacterial extract to finished capsules; laboratories, production lines, active ingredients, capsules and packaging.
Pharmaceutical partnerships
International partnerships, out-licensing and in-licensing for the portfolio and the R&D pipeline, with a global network of partners.
Trust & reputation

ranQ Trust Score of OM Pharma SA: 4.2 out of 5.0

Trust Score4.2/ 5.0

Very high

x

Data basis 100% · As of October 2026

OM Pharma SA scores 62.7 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.55.024%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.61.010%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.88.08%
OM Pharma SA scores 95.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.96.07%
OM Pharma SA scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
OM Pharma SA scores 63.4 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.100.04%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.26.74%
Qualifications+0.00

OM Pharma SA reaches a ranQ Trust Score of 4.2 out of 5.0 — rated «Very high». The rating draws, among other things, on 3.9 out of 5 stars from 10 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
3.9
of 5

Aggregated from 10 reviews across all connected sources

Sources
GGoogle3.910
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

March 20, 2026Media
OM Pharma fête 80 ans de présence à Meyrin
agefi.com
December 13, 2024Media
Etienne Jornod, président d’OM Pharma à Genève: «Il ne faut pas baisser le prix des médicaments de façon linéaire
letemps.ch
October 27, 2023Media
Un an après les restructurations: Nouveaux licenciements en série chez OM Pharma
tdg.ch

Knowledge

No knowledge articles yet

Once OM Pharma SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

OM Pharma SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank OM Pharma SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of OM Pharma SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Rue du Bois-du-Lan 22
1217 Meyrin
Opening hours
Mon
08:00 - 12:00, 13:00 - 17:00
Tue
08:00 - 12:00, 13:00 - 17:00
Wed
08:00 - 12:00, 13:00 - 17:00
Thu
08:00 - 12:00, 13:00 - 17:00
Fri
08:00 - 12:00, 13:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-103.159.324
Founded
1937 · 89 years
Last commercial register change
August 13, 2026
Employees
101 to 500
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    LP
    Labatec Pharma SA
    Meyrin
    MM
    MMV MEDICINES FOR MALARIA VENTURE
    Cointrin
    LL
    Luminar Life Sciences SA
    Vandoeuvres
    IH
    IQONE HEALTHCARE SWITZERLAND SA
    Versoix
    CS
    Columed SA
    Geneva
    CH
    Corsano Health SA
    Plan-Les-Ouates
    KB
    KBI Biopharma SA
    Plan-Les-Ouates
    NS
    NovImmune SA
    Plan-Les-Ouates